These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 33104238)

  • 41. Captopril-induced DRESS: first reported case confirmed by patch test.
    Chaabane A; Fadhl NB; Chadly Z; Fredj NB; Boughattas NA; Aouam K
    Dermatitis; 2013; 24(5):255-7. PubMed ID: 24030372
    [No Abstract]   [Full Text] [Related]  

  • 42. Drug reaction with eosinophilia and systemic symptoms/drug-induced hypersensitivity syndrome (DRESS/DIHS) caused by levofloxacin in a patient with systemic scleroderma, rheumatoid arthritis, and Sjogren syndrome.
    Matsumoto T; Horino T; Inotani S; Ichii O; Terada Y
    Contact Dermatitis; 2019 Apr; 80(4):253-254. PubMed ID: 30484869
    [No Abstract]   [Full Text] [Related]  

  • 43. DRESS syndrome.
    Descamps V; Ranger-Rogez S
    Joint Bone Spine; 2014 Jan; 81(1):15-21. PubMed ID: 23816504
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Carbamazepine-induced DRESS with severe eosinophilia confirmed by positive patch test.
    Fathallah N; Slim R; Rached S; Ben Salem C; Ghariani N; Nouira R
    Dermatitis; 2014; 25(5):282-4. PubMed ID: 25207696
    [No Abstract]   [Full Text] [Related]  

  • 45. DRESS syndrome: a detailed insight.
    Behera SK; Das S; Xavier AS; Selvarajan S
    Hosp Pract (1995); 2018 Aug; 46(3):152-162. PubMed ID: 29519170
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome.
    Cardones AR
    Clin Dermatol; 2020; 38(6):702-711. PubMed ID: 33341203
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HLA-A*32:01 is strongly associated with vancomycin-induced drug reaction with eosinophilia and systemic symptoms.
    Konvinse KC; Trubiano JA; Pavlos R; James I; Shaffer CM; Bejan CA; Schutte RJ; Ostrov DA; Pilkinton MA; Rosenbach M; Zwerner JP; Williams KB; Bourke J; Martinez P; Rwandamuriye F; Chopra A; Watson M; Redwood AJ; White KD; Mallal SA; Phillips EJ
    J Allergy Clin Immunol; 2019 Jul; 144(1):183-192. PubMed ID: 30776417
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterizing DRESS syndrome recurrence: a systematic review.
    Sharma AN; Shwe S; Ravi V; Miller M; Mesinkovska NA; Rojek NW; Worswick S
    Arch Dermatol Res; 2022 Oct; 314(8):721-728. PubMed ID: 34505944
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Viral rashes mimicking drug reaction with eosinophilia and systemic symptoms syndrome in children after β-lactams intake: a diagnostic challenge.
    Dondi A; Parladori R; Mori F; Liccioli G; Bassi A; Lanari M; Patrizi A; Neri I
    Eur J Pediatr; 2021 Jul; 180(7):2327-2332. PubMed ID: 33686529
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome Induced by Levetiracetam in a Pediatric Patient.
    Bayram AK; Canpolat M; Çınar SL; Tahan F; Gumus H; Kumandaş S; Per H
    J Emerg Med; 2016 Feb; 50(2):e61-6. PubMed ID: 26597350
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Severe skin eruption with features of drug reaction with eosinophilia and systemic symptoms (DRESS) during vemurafenib treatment of melanoma.
    Kohlmann J; Reschke R; Mockenhaupt M; Ziemer M
    J Eur Acad Dermatol Venereol; 2022 Mar; 36(3):e242-e244. PubMed ID: 34704628
    [No Abstract]   [Full Text] [Related]  

  • 52. Fever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergy.
    Pavlos R; Mallal S; Ostrov D; Pompeu Y; Phillips E
    J Allergy Clin Immunol Pract; 2014; 2(1):21-33. PubMed ID: 24565765
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of antiviral medications in drug reaction with eosinophilia and systemic symptoms (DRESS): A case of infantile DRESS.
    Chow ML; Kim D; Kamath S; Peng D; Luu M
    Pediatr Dermatol; 2018 Mar; 35(2):e114-e116. PubMed ID: 29334124
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Drug reaction with eosinophilia and systemic symptoms due to carbamazepine. Pediatric case].
    Pereira-Ospina RDP; Bejarano-Quintero AM; Suescún-Vargas JM; Pinzón-Salamanca JY
    Arch Argent Pediatr; 2018 Jun; 116(3):e433-e436. PubMed ID: 29756718
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prediction and management of drug reaction with eosinophilia and systemic symptoms (DRESS).
    Shiohara T; Kano Y; Hirahara K; Aoyama Y
    Expert Opin Drug Metab Toxicol; 2017 Jul; 13(7):701-704. PubMed ID: 28633581
    [No Abstract]   [Full Text] [Related]  

  • 56. [DRESS syndrome secondary to antituberculosis drugs: about a case].
    Jridi S; Azzeddine R; Bourkadi JE
    Pan Afr Med J; 2017; 27():37. PubMed ID: 28761613
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Drug reaction with eosinophilia and systemic symptoms syndrome (DRESS) syndrome associated with azithromycin presenting like septic shock: a case report.
    Sriratanaviriyakul N; Nguyen LP; Henderson MC; Albertson TE
    J Med Case Rep; 2014 Oct; 8():332. PubMed ID: 25297051
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Trimetazidine, a hitherto unreported cause of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome.
    Singh S; Khurana A; Muddebihal A; Jangra M
    Contact Dermatitis; 2021 Mar; 84(3):208-210. PubMed ID: 33034892
    [No Abstract]   [Full Text] [Related]  

  • 59. Raltegravir-induced drug reaction with eosinophilia and systemic symptoms syndrome in a child.
    Scaggs FA; Aziz MS; Palmisano EL; Mahdavinia M; Raikar SS; Logan LK
    Ann Allergy Asthma Immunol; 2016 Dec; 117(6):719-721. PubMed ID: 28073704
    [No Abstract]   [Full Text] [Related]  

  • 60. Sequential screening of biomarkers in a case of drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms occurring with virus reactivation and autoimmune disease.
    Lee E; Lee S; Tashiro Y; Ogihara M; Watanabe H; Ishibashi S; Nagata S; Miyo K; Ohara M; Otsuki T; Sueki H
    J Dermatol; 2022 Jul; 49(7):e221-e223. PubMed ID: 35243680
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.